Margreet G E M Ausems
Overview
Explore the profile of Margreet G E M Ausems including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
3698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beekman M, Terra L, Heemskerk-Gerritsen B, van der Aalst C, Roeters van Lennep J, van Beurden M, et al.
JACC CardioOncol
. 2025 Jan;
6(6):922-931.
PMID: 39801648
Background: Premenopausal risk-reducing salpingo-oophorectomy (RRSO) in women at high familial risk of ovarian cancer leads to immediate menopause. Although early natural menopause is associated with increased cardiovascular disease risk, evidence...
2.
Vlaming M, Ausems M, Kiemeney L, Schijven G, van Melick H, Noordzij M, et al.
Prostate Cancer Prostatic Dis
. 2024 Dec;
PMID: 39639158
Background: International guidelines recommend germline genetic testing for men with metastatic prostate cancer. If offered to all patients by genetic healthcare professionals, there will be insufficient capacity to cope with...
3.
Stroot I, Bart J, Hollema H, Wagner M, Yigit R, van Doorn H, et al.
J Natl Cancer Inst
. 2024 Nov;
PMID: 39579093
Background: Risk-reducing salpingo-oophorectomy (RRSO) effectively prevents high-grade serous carcinoma (HGSC) in BRCA1/2 germline pathogenic variant (GPV) carriers. Still, some women develop HGSC after RRSO without pathologic findings. This study assessed...
4.
Schreurs M, Adank M, Hollestelle A, de Groot R, Stommel-Jenner D, van Asperen C, et al.
BMJ Open
. 2024 Oct;
14(10):e086688.
PMID: 39384226
Purpose: c.1100delC is associated with an increased breast cancer risk in women. While this variant is prevalent in the Netherlands (1% in the general population), knowledge of aetiology and prognosis...
5.
Yang X, Mooij T, Leslie G, Ficorella L, Andrieu N, Kast K, et al.
J Med Genet
. 2024 Jun;
61(8):803-809.
PMID: 38834293
Background: No validation has been conducted for the BOADICEA multifactorial breast cancer risk prediction model specifically in pathogenic variant (PV) carriers to date. Here, we evaluated the performance of BOADICEA...
6.
Schreurs M, Schmidt M, Hollestelle A, Schaapveld M, van Asperen C, Ausems M, et al.
Genet Med
. 2024 Jun;
26(9):101171.
PMID: 38828701
Purpose: Female CHEK2 c.1100delC heterozygotes are eligible for additional breast surveillance because of an increased breast cancer risk. Increased risks for other cancers have been reported. We studied whether CHEK2...
7.
Witjes V, Hermkens D, Swillens J, Smolders Y, Mourits M, Ausems M, et al.
Fam Cancer
. 2024 May;
23(4):429-436.
PMID: 38811422
Genetic testing in patients with ovarian carcinoma (OC) is crucial, as around 10-15% of these women have a genetic predisposition to OC. Although guidelines have recommended universal germline testing for...
8.
Stroot I, Bart J, Hollema H, Jalving M, Wagner M, Yigit R, et al.
Gynecol Oncol
. 2024 May;
187:198-203.
PMID: 38795508
Objective: The aim of this study was to describe the long-term outcome of asymptomatic BRCA1/2 germline pathogenic variant (GPV) carriers with high-grade serous carcinoma (HGSC) in their risk-reducing salpingo-oophorectomy (RRSO)...
9.
Vlaming M, Ausems M, Schijven G, van Oort I, Kets C, Komdeur F, et al.
Fam Cancer
. 2024 May;
23(2):165-175.
PMID: 38722431
Some patients with metastatic prostate cancer carry a pathogenic germline variant (PV) in a gene, that is mainly associated with an increased risk of breast cancer in women. If they...
10.
Bruins D, Onstwedder S, Cornel M, Ausems M, van Mil M, Rigter T
Genes (Basel)
. 2024 Apr;
15(4).
PMID: 38674451
: Previous studies have suggested that information offered by sellers of health-related direct-to-consumer genetic tests (DTC-GTs) is often incomplete, unbalanced, or too difficult to understand. The extent to which this...